Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Novel TCR-like CAR-T cells targeting an HLA∗0201-restricted SSX2 epitope display strong activity against acute myeloid leukemia

Molecular Therapy — Methods & Clinical Development(2021)10.1016/j.omtm.2021.09.008Source: DataRank Database

Novel TCR-like CAR-T cells targeting an HLA∗0201-restricted SSX2 epitope display strong activity against acute myeloid leukemia is a research paper published in Molecular Therapy — Methods & Clinical Development (2021). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 1.46)OA: goldTopics (27)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Stacey Van Pelt ORCID,Keri Toner ORCID,Preethi B. Balakrishnan ORCID,Hema Dave ORCID,Catherine M. Bollard ORCID

Live enrichment

PubMed:34729377 PMC:PMC8526777 OpenAlex:https://openalex.org/W3202023872

The George Washington University Dr Cyrus and Myrtle Katzen Cancer Research Center

National Institutes of Health

FWCI

1.46

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

goldLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S2329050121001467/pdf

publisherhttp://www.cell.com/article/S2329050121001467/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2329050121001467?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2329050121001467?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.omtm.2021.09.008

Fields of Study

CAR-T cell therapy researchImmunotherapy and Immune ResponsesSilicon Carbide Semiconductor Technologies

Keywords

BiologyChimeric antigen receptorMyeloid leukemiaEpitopeCancer researchT-cell receptorCD8Molecular biologyAntigenCancer immunotherapyT cellImmunotherapyImmunologyImmune systemAMlAcute myeloid leukemiaCTACancer-testis antigenCellular TherapyCarSsxTcr-like AntibodyT Cell Receptor-like AntibodySynovial Sarcoma X Breakpoint

Sustainable Development Goals

SDG 0: Good health and well-being